REDWOOD CITY, Calif.–(BUSINESS WIRE)–Avinger, Inc., a medical device manufacturer of innovative,
multi-functional catheters for treating patients with Peripheral Artery Disease
(PAD), announces today the release of two new products, Kittycat 2, a smaller
more refined ultimate support catheter, and Juicebox, a battery-powered
accessory that automatically rotates the distal tip of Avingers catheters.

Kittycat 2s novel features truly go the distance, offering
extra length to reach diseased peripheral arteries, therefore enabling
subsequent treatment. The catheters design provides a gentle approach for
lesion access, using a spiral fluted tip and 150cm length to create a nimble
tour guide in small spaces and around tight bends. The pre-shaped tip of
Kittycat 2 can be adjusted to fit the unique needs of the particular procedure,
and is designed to traverse contoured anatomy and access discreet regions in
the peripheral vasculature. The shaft system was created to offer responsive
force transmission through the entire length of the shaft. Combined with torque
control, Kittycat 2 is the ultimate support catheter and is compatible with
Juicebox, providing further usability.

Juicebox, an accessory to Avingers pioneering catheters,
simplifies procedures by providing battery-powered rotation to the distal tip
of the catheter, allowing the physician to focus on gently guiding the catheter
instead of concentrating on tip rotation. Juicebox spins at a constant speed of
100 rpm in either the clockwise or counterclockwise direction and can be easily
added or removed during the procedure.

“The release of these two devices reaffirms our commitment
to improving patient outcomes,” said founder and Chief Executive Officer John
B. Simpson PhD, MD. “By making our products even more agile and easy to use,
physicians can really tackle those difficult cases that have presented a
challenge in the past. We are now more equipped than ever to help as many
patients as possible.”

Kittycat 2 is now available for purchase and Juicebox is
included automatically with Wildcat and Kittycat 2 catheters.

ABOUT AVINGER

Founded in 2007 by renowned cardiologist and medical device entrepreneur Dr.
John B. Simpson, Avinger develops next-generation catheter-based technologies
for the treatment of peripheral artery disease (PAD). Leveraging core
competencies in medical device catheter engineering and intravascular OCT,
Avinger markets Wildcat and Kittycat catheters, and recently received CE Mark
to market Ocelot, the first ever real-time OCT crossing catheter. www.avinger.com.